drugset
drugset / Trial / NCT03020368

Effectiveness and Safety of Breeded Leech for Symptomatic Primary Arthrosis of the First Carpometacarpal Joint

NCT03020368 ↗

Terminated 52 enrolled Charite University, Berlin, Germany
RandomizedParallel-groupSingle-blindTreatment

Summary

In this trial the investigators want to prove the efficacy and safety of a one-time topical leech application at patients with symptomatic primary arthrosis of the first carpometacarpal joint in comparison to the standard therapy with topical diclofenac.

Timeline

Start
2017-01
Primary completion
2018-12
Completion
2018-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac Other / unclassified 10 mg Topical
Subject Medileech Unknown — Topical

Indications

No indication recorded.